Pharma market sees 6.1% growth in October despite subdued volumes

Amongst the top 10 therapies that contribute to more than 90% of the Indian pharma market, price drove growth in the cardiac segment. The anti-hypertensives, which account for almost 50% of the cardiac segment, is experiencing stagnated volume growth. Lipid-lowering drugs and platelet aggregation inhibitors have shown a relatively higher growth to help boost the cardiac segment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9gUHqbF
via IFTTT